Skip to main navigation Skip to search Skip to main content

Control systems technology in the advanced manufacturing of biologic drugs

  • Amos E. Lu
  • , Joel A. Paulson
  • , Nicholas J. Mozdzierz
  • , Alan Stockdale
  • , Ashlee N.Ford Versypt
  • , Kerry R. Love
  • , J. Christopher Love
  • , Richard D. Braatz
  • Massachusetts Institute of Technology

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

16 Scopus citations

Abstract

The paper focuses on systems engineering challenges for biomanufacturing, as exemplified by the Integrated and Scalable Cyto-Technology (InSCyT) bio-manufacturing platform under the Defense Advanced Research Projects Agency (DARPA) Biologically-derived Medicines on Demand (Bio-MOD) program. One goal of the project is to apply modeling and simulation techniques to the design, control, and optimization of biomanufacturing operations. In this paper, we present models and control strategies for the unit operations within the InSCyT platform, including a perfusion bioreactor, several packed bed and membrane chromatography steps, and a conductivity- and pH-controlled buffer mixing unit.

Original languageEnglish
Title of host publication2015 IEEE Conference on Control and Applications, CCA 2015 - Proceedings
PublisherInstitute of Electrical and Electronics Engineers Inc.
Pages1505-1515
Number of pages11
ISBN (Electronic)9781479977871
DOIs
StatePublished - Nov 4 2015
EventIEEE Conference on Control and Applications, CCA 2015 - Sydney, Australia
Duration: Sep 21 2015Sep 23 2015

Publication series

Name2015 IEEE Conference on Control and Applications, CCA 2015 - Proceedings

Conference

ConferenceIEEE Conference on Control and Applications, CCA 2015
Country/TerritoryAustralia
CitySydney
Period09/21/1509/23/15

Fingerprint

Dive into the research topics of 'Control systems technology in the advanced manufacturing of biologic drugs'. Together they form a unique fingerprint.

Cite this